γ-Synuclein interacts with phospholipase Cβ2 to modulate G protein activation

Autor: V. Siddhartha Yerramilli, Cassandra Zurawsky, Suzanne Scarlata, Urszula Golebiewska, Narindra Khalikaprasad, Yuanjian Guo
Jazyk: angličtina
Rok vydání: 2012
Předmět:
Protein Folding
animal diseases
Phospholipase C beta
lcsh:Medicine
Plasma protein binding
Biochemistry
Mass Spectrometry
gamma-Synuclein
0302 clinical medicine
Molecular Cell Biology
Fluorescence Resonance Energy Transfer
Signaling in Cellular Processes
lcsh:Science
Calcium signaling
0303 health sciences
Multidisciplinary
Signaling Cascades
Cell biology
Gene Expression Regulation
Neoplastic

Gq alpha subunit
030220 oncology & carcinogenesis
Research Article
Signal Transduction
Protein Binding
G protein
Biophysics
Breast Neoplasms
RAC1
Biology
Gene Expression Regulation
Enzymologic

03 medical and health sciences
GTP-binding protein regulators
GTP-Binding Proteins
Cell Line
Tumor

mental disorders
Humans
Calcium Signaling
Binding site
Protein Interactions
030304 developmental biology
Binding Sites
Gamma-synuclein
lcsh:R
Proteins
Protein Structure
Tertiary

nervous system diseases
Microscopy
Fluorescence

nervous system
Calcium Signaling Cascade
biology.protein
lcsh:Q
Zdroj: PLoS ONE, Vol 7, Iss 8, p e41067 (2012)
PLoS ONE
ISSN: 1932-6203
Popis: Phospholipase Cβ2 (PLC β2) is activated by G proteins and generates calcium signals in cells. PLCβ2 is absent in normal breast tissue, but is highly expressed in breast tumors where its expression is correlated with the progression and migration of the tumor. This pattern of expression parallels the expression of the breast cancer specific gene protein 1 which is also known as γ-synuclein. The cellular function of γ-synuclein and the role it plays in proliferation are unknown. Here, we determined whether γ-synuclein can interact with PLCβ2 and affect its activity. Using co-immunprecitation and co-immunofluorescence, we find that in both benign and aggressive breast cancer cell lines γ-synuclein and PLCβ2 are associated. In solution, purified γ-synuclein binds to PLCβ2 with high affinity as measured by fluorescence methods. Protease digestion and mass spectrometry studies show that γ-synuclein binds to a site on the C-terminus of PLCβ2 that overlaps with the Gαq binding site. Additionally, γ-synuclein competes for Gαq association, but not for activators that bind to the N-terminus (i.e. Rac1 and Gβγ). Binding of γ-synuclein reduces the catalytic activity of PLCβ2 by mechanism that involves inhibition of product release without affecting membrane interactions. Since activated Gαq binds more strongly to PLCβ2 than γ-synuclein, addition of Gαq(GTPγS) to the γ-synuclein -PLCβ2 complex allows for relief of enzyme inhibition along with concomitant activation. We also find that Gβγ can reverse γ-synuclein inhibition without dissociating the γ-synuclein- PLCβ2- complex. These studies point to a role of γ-synuclein in promoting a more robust G protein activation of PLCβ2.
Databáze: OpenAIRE